Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
AEMPS · 17 medicines
FDA · 17 medicines
AIFA · 13 medicines
Anvisa · 12 medicines
SFDA · 12 medicines · Historical list
MS · 7 medicines · Historical list
PHARMAC · 5 medicines
HSA · 3 medicines
HALMED · 2 medicines
ALIMS · 2 medicines
EMA · 1 medicine · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
5 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Sumatriptan Viatris | New Zealand | Tab 100 mg | Funded | ||
| Sumatriptan Viatris | New Zealand | Tab 50 mg | Funded | ||
| Sumagran | New Zealand | Tab 100 mg | Funded | ||
| Sumagran | New Zealand | Tab 50 mg | Funded | ||
| Clustran | New Zealand | Inj 12 mg per ml, 0.5 ml prefilled pen | Funded |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, MS, PHARMAC and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
